{"id":59857,"date":"2020-12-21T22:59:19","date_gmt":"2020-12-21T14:59:19","guid":{"rendered":"https:\/\/www.chinapulse.com\/?p=150079"},"modified":"2020-12-21T22:59:19","modified_gmt":"2020-12-21T14:59:19","slug":"china-cansinobios-covid-19-vaccine-trials-recruit-over-20000-people-2","status":"publish","type":"post","link":"https:\/\/www.chinalegalblog.com\/en\/2020\/12\/21\/china-cansinobios-covid-19-vaccine-trials-recruit-over-20000-people-2\/","title":{"rendered":"China CanSinoBIO's COVID-19 vaccine trials recruit over 20,000 people"},"content":{"rendered":"<p>BEIJING (Reuters) &#8211; China&#8217;s CanSino Biologics Inc has recruited over 20,000 participants for late-stage human trials overseas for its coronavirus vaccine, a health official said on Monday.<\/p>\n<p>The candidate, known as Ad5-nCoV or Convidecia, which CanSinoBIO is jointly developing with a research institute backed by the Chinese military, is among the five vaccines China has moved into Phase 3 clinical trials to test their efficacy.&#8230;<\/p>\n<p>This news comes via <a href=\"https:\/\/www.chinapulse.com\/\"  title=\"Best source for Chinese news in English\">ChinaPulse.com, which delivers news, data, analysis, and insights on Chinese business, travel, finance, health, military, investment, and technology<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>BEIJING (Reuters) &#8211; China's CanSino Biologics Inc has recruited over 20,000 participants for late-stage human trials overseas for its coronavirus vaccine, a health official said on Monday.<br \/>\nThe candidate, known as Ad5-nCoV or Convidecia, whi&#8230;<\/p>\n","protected":false},"author":250,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[65,144,213,288,194,249],"tags":[2211,3472,10323,10324,2486,2240,2961,7035],"class_list":["post-59857","post","type-post","status-publish","format-standard","hentry","category-beijing","category-china","category-china-news","category-medicine","category-news-chinese-law","category-russia","tag-argentina","tag-chinese","tag-coronavirus","tag-covid-19","tag-mexico","tag-military","tag-pakistan","tag-vaccine"],"_links":{"self":[{"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/posts\/59857"}],"collection":[{"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/users\/250"}],"replies":[{"embeddable":true,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/comments?post=59857"}],"version-history":[{"count":1,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/posts\/59857\/revisions"}],"predecessor-version":[{"id":59858,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/posts\/59857\/revisions\/59858"}],"wp:attachment":[{"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/media?parent=59857"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/categories?post=59857"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/tags?post=59857"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}